AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $372,000 | +92.7% | 35,652 | +113.8% | 0.02% | +228.6% |
| Q4 2021 | $193,000 | -70.9% | 16,678 | -76.0% | 0.01% | -79.4% |
| Q3 2021 | $664,000 | +84.4% | 69,573 | +86.2% | 0.03% | +126.7% |
| Q2 2021 | $360,000 | -48.0% | 37,361 | -46.7% | 0.02% | -61.5% |
| Q1 2021 | $692,000 | +198.3% | 70,039 | +595.9% | 0.04% | +105.3% |
| Q4 2020 | $232,000 | +3.6% | 10,064 | -56.2% | 0.02% | +5.6% |
| Q4 2019 | $224,000 | +55.6% | 22,982 | +27.6% | 0.02% | +100.0% |
| Q3 2019 | $144,000 | – | 18,009 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |